Ricerca
La gestione della broncopolmonite nel Friuli Venezia Giulia
BRONCHOPNEUMONIA MANAGEMENT IN FRIULI VENEZIA GIULIA (ITALY)
CRISTINA MILOCCO, LUCA RONFANI*, DINO FARAGUNA
Dipartimento Materno-Infantile Ass 2, Monfalcone-Gorizia
*Servizio di Epidemiologia e Biostatistica, IRCCS “Burlo Garofolo”, Trieste
Aprile 2008 - pagg. 244 -250
Abstract
The objective of our study was to describe the spectrum of clinical features necessary for
diagnosis and actual treatment of community-acquired pneumonia in children in northern
Italy. It was a prospective observational study of paediatric pneumonia diagnosed in outpatient
settings and in 9 hospitals in northern Italy from January to December 2004 in comparison
to a previous study made 20 years before in the same area. Our study demonstrated
a high rate of clinical diagnosis of CAP made by primary care paediatricians (93%)
according to recent evidence-based guidelines on diagnosis and treatment of paediatric
pneumonia; a decrease in hospital admissions (1/3 of total diagnosis) for CAP and a
lower rate of antibiotic therapy by intravenous administration in hospital admissions (only
in the 46% vs 74% 20 years ago). Despite these recent improvements in management of
CAP, clinical assessment of children influenced independently management of pneumonia
including admission to hospital and route of administration.
Parole chiave
Classificazione MeSH
Bibliografia
1. Ewing S, Torres A. Severe community-acquired
pneumonia: how to assess illness severity.
Arch Chest Dis 1999;54:250-4.
2. Esposito S, Blasi F, Allegra L. Use of antimicrobial for community-acquired lower respiratiry tract infections in hospitalised children. Eur J Microbiol Infect Dis 2001;20:647- 50.
3. Longo G, Strinati R, Faraguna D, et al. Indagine policentrica sulle broncopolmoniti trattate in ambiente ospedaliero in Friuli Venezia Giulia. 1 Epidemiologia. Ped Med Chir 1986; 8:495-500.
4. Longo G, Strinati R, Faraguna D, et al. Indagine policentrica sulle broncopolmoniti trattate in ambiente ospedaliero in Friuli Venezia Giulia. 2 Antibioticoterapia. Ped Med Chir 1986;8:501-8.
5. Boschi G, Marchetti F, Mercuri B, La Gamba G. La broncopolmonite. Medico e Bambino 1999;18(4):236-41.
6. Lakhanpaul M, Atkinson M, Stephenson T. Community-acquired pneumonia in children: a clinical update. Arch Dis Child Educ Pract Ed 2004;89:ep29-ep34.
7. British Thoracic Society of Standards of Care Committee. BTS Guidelines for the management of community-acquired pneumonia in children. Thorax 2002;57:i1-124.
8. Clark JE, Hammal D, Spencer D, Hampton F. Children with pneumonia: how do they present and how are they managed? Arch Dis Child 2007;92:394-8.
9. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002;346:429- 37.
10. Rossignoli A, Clavenna A, Bonati M. Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000-2005. Eur J Clin Pharmacol 2007;63:1099-106.
11. Dati EARSS. European Antimicrobial Resistance Surveillance System 2004 www.rivm. nl/earss/result/Monitoring_reports.
12. Deguchi K, Yokota N, Koguchi M, et al. Antibacterial activity of rokitamycin against fresh clinical isolates. Jnp J Antibiot 1992;45 (12):1609-21.
13. Zhanel GG, Dueck M, Hoban GJ, et al. Review of macrolides and ketolides: focus on respiratory tract infections. Drugs 2001;61(4): 443-98.
14. Suzuki S, Tsutomu Y, Narita M, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicr Agents Chemiother 2006;50:709-12.
15. Hazir T, Qazi SA, Bin Nisar Y, et al. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan. Arch Dis Child 2007; 92:291-7.
2. Esposito S, Blasi F, Allegra L. Use of antimicrobial for community-acquired lower respiratiry tract infections in hospitalised children. Eur J Microbiol Infect Dis 2001;20:647- 50.
3. Longo G, Strinati R, Faraguna D, et al. Indagine policentrica sulle broncopolmoniti trattate in ambiente ospedaliero in Friuli Venezia Giulia. 1 Epidemiologia. Ped Med Chir 1986; 8:495-500.
4. Longo G, Strinati R, Faraguna D, et al. Indagine policentrica sulle broncopolmoniti trattate in ambiente ospedaliero in Friuli Venezia Giulia. 2 Antibioticoterapia. Ped Med Chir 1986;8:501-8.
5. Boschi G, Marchetti F, Mercuri B, La Gamba G. La broncopolmonite. Medico e Bambino 1999;18(4):236-41.
6. Lakhanpaul M, Atkinson M, Stephenson T. Community-acquired pneumonia in children: a clinical update. Arch Dis Child Educ Pract Ed 2004;89:ep29-ep34.
7. British Thoracic Society of Standards of Care Committee. BTS Guidelines for the management of community-acquired pneumonia in children. Thorax 2002;57:i1-124.
8. Clark JE, Hammal D, Spencer D, Hampton F. Children with pneumonia: how do they present and how are they managed? Arch Dis Child 2007;92:394-8.
9. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002;346:429- 37.
10. Rossignoli A, Clavenna A, Bonati M. Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000-2005. Eur J Clin Pharmacol 2007;63:1099-106.
11. Dati EARSS. European Antimicrobial Resistance Surveillance System 2004 www.rivm. nl/earss/result/Monitoring_reports.
12. Deguchi K, Yokota N, Koguchi M, et al. Antibacterial activity of rokitamycin against fresh clinical isolates. Jnp J Antibiot 1992;45 (12):1609-21.
13. Zhanel GG, Dueck M, Hoban GJ, et al. Review of macrolides and ketolides: focus on respiratory tract infections. Drugs 2001;61(4): 443-98.
14. Suzuki S, Tsutomu Y, Narita M, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicr Agents Chemiother 2006;50:709-12.
15. Hazir T, Qazi SA, Bin Nisar Y, et al. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan. Arch Dis Child 2007; 92:291-7.
Corrispondenza: ronfani@burlo.trieste.it